Agree, high expense for a company with only about 15mln cash and another inevitable huge share dilution coming next year in regards with the human trials. Thinking partnership would be a better option.
But try to look positively to the Phase 1/2 which may finally bring the so long waited success for many auzzie investors.
It’s been very long journey.
